Vaccination with type-1 dendritic cells pulsed with multiple glioma-associated antigen peptides in combination with POLY-ICLC in patients with recurrent malignant glioma

被引：0

作者：

Okada, Hideho ^{[1
]}

Lieberman, Frank ^{[1
]}

Kalinski, Pawel ^{[1
]}

Zhu, Xinmei ^{[1
]}

Lunsford, L. Dade ^{[1
]}

Kassam, Amin ^{[1
]}

Mintz, Arlan

Bartlett, David ^{[1
]}

Brown, Charles

Zeh, Herbert ^{[1
]}

Whiteside, Theresa ^{[1
]}

Butterfield, Lisa ^{[1
]}

Hamilton, Ronald ^{[1
]}

Salazar, Andres ^{[2
]}

Pollack, Ian ^{[1
]}

机构：

[1] Univ Pittsburgh, Pittsburgh, PA USA

[2] Oncovir Inc, Washington, DC USA

来源：

NEURO-ONCOLOGY | 2007年 / 9卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：508 / 508

页数：1

共 45 条

[41] TVI-BRAIN-1-A PHASE I STUDY TO TEST THE SAFETY OF A COMBINATION OF AUTOLOGOUS CANCER CELL VACCINATION, ADOPTIVE TRANSFER OF CANCER ANTIGEN-SPECIFIC EFFECTOR T CELLS AND LOW-DOSE INTERLEUKIN 2 DURING TREATMENT OF PATIENTS WITH RECURRENT GRADE III/IV GLIOMA
Salacz, Michael E.
Camarata, Paul J.
Ots, Max
McIntire, Jennifer
Lovick, Darren
NEURO-ONCOLOGY, 2012, 14 : 47 - 47
[42] A PHASE I CLINICAL TRIAL ON THE INTRACRANIAL ADMINISTRATION OF AUTOLOGOUS CD1C(BDCA-1)+ /CD141(BDCA-3)+ MYELOID DENDRITIC CELLS IN COMBINATION WITH IPILIMUMAB AND NIVOLUMAB IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA
Duerinck, J.
Lescrauwaet, L.
Dirven, I
Del'haye, J.
Cammaert, M.
Geens, W.
Geeraerts, X.
Stevens, L.
Brock, S.
Kockx, M.
Everaert, H.
Vanbinst, A.
Tuyaerts, S.
Neyns, B.
NEURO-ONCOLOGY, 2024, 26 : V17 - V17
[43] A phase I clinical trial on the intracranial administration of autologous CD1c(BDCA-1)+ /CD141(BDCA-3)+ myeloid dendritic cells (myDC) in combination with ipilimumab (IPI) and nivolumab (NIVO) in patients with recurrent high-grade glioma (rHGG)
Neyns, B.
Dirven, I.
Lescrauwaet, L.
Cammaert, M.
Geens, W.
Geeraerts, X.
Stevens, L.
Brock, S.
Kockx, M.
Everaert, H.
Van Binst, A-M.
Tuyaerts, S.
Duerinck, J.
ANNALS OF ONCOLOGY, 2024, 35 : S406 - S407
[44] IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro
Vujanovic, L.
Ranieri, E.
Gambotto, A.
Olson, W. C.
Kirkwood, J. M.
Storkus, W. J.
CANCER GENE THERAPY, 2006, 13 (08) : 798 - 805
[45] IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro
L Vujanovic
E Ranieri
A Gambotto
W C Olson
J M Kirkwood
W J Storkus
Cancer Gene Therapy, 2006, 13 : 798 - 805

← 1 2 3 4 5 →